Neogen Corporation Class Action Lawsuit Overview
Investors are urged to take notice: Neogen Corporation (NASDAQ: NEOG) is currently embroiled in a class action lawsuit that is gaining traction as the lead plaintiff deadline approaches. If you have experienced losses exceeding $100,000 due to investment in Neogen, it is crucial to be aware of your rights and the steps you can take.
Important Deadlines and Legal Rights
The lawsuit pertains to purchases made between January 5, 2023, and June 3, 2025. Investors need to file their lead plaintiff applications by the specified deadline to participate in this legal proceeding. This case is being heard in the United States District Court for the Western District of Michigan.
What Actions Can Investors Take?
If you hold shares in Neogen and are seeking legal counsel or wish to understand the implications of this lawsuit on your financial situation, it’s advisable to contact your representative as soon as possible. Engaging an attorney familiar with securities class actions can help clarify your options.
Allegations Against Neogen Corporation
Neogen Corporation and some of its executives are being accused of failing to communicate crucial information to investors during the defined Class Period. These alleged omissions may have violated federal securities laws, impacting the stock price and, subsequently, the investments of many.
Recent Corporate Developments
Recent disclosures from Neogen have raised multiple concerns among shareholders. In April 2025, Neogen announced a revenue decline of 3.4% leading to a significant revision of its fiscal guidance. This announcement, particularly the reported decrease in quarterly revenue attributed to integration issues, sent shares tumbling by 28% to a closing price of $5.02 per share.
The situation deteriorated further when Neogen indicated on June 4, 2025, that EBITDA margins would likely drop to the high-teens, starkly lower than previous profit margins. Following this news, the share price fell an additional 17%, closing at $4.96.
Understanding the Lawsuit
The ongoing lawsuit aims to hold Neogen accountable for providing misleading information, which investors believe directly contributed to their financial losses. Shareholders are encouraged to stay informed about court proceedings and any potential resolutions of the case that may ensure restitution for those impacted.
About Kahn Swick & Foti, LLC
Kahn Swick & Foti, LLC, known for its robust legal expertise in securities litigation, is spearheading this lawsuit. With a track record that includes ranking among the top firms nationally based on settlement value, KSF is committed to advocating for investors’ rights. They represent clients from diverse backgrounds, focusing on recovering losses resulting from corporate misconduct.
Frequently Asked Questions
What is the current status of the class action lawsuit against Neogen?
The lawsuit is ongoing, with a deadline for filing lead plaintiff applications approaching. Interested investors should act promptly to secure their position.
How can I participate in the class action lawsuit?
If eligible, you can file a lead plaintiff application through legal counsel. It’s advisable to consult with an attorney specializing in securities class actions for effective representation.
What should I know about my rights as an investor in this lawsuit?
As a shareholder, you have the right to seek restitution for your financial losses incurred during the Class Period, especially if you can demonstrate the impact of the alleged misinformation.
What are the main allegations against Neogen Corporation?
The primary allegations concern the company’s failure to disclose significant information that may have misled investors and affected stock valuations during the Class Period.
Where can I get more information about Kahn Swick & Foti, LLC?
You can visit KSF’s website to learn about their services and the latest updates regarding current litigation.
